T2 Biosystems (TTOO) Stock Price, News & Analysis

Company Overview

T2 Biosystems, Inc. is a medical diagnostics company focused on developing and commercializing technologies for the rapid detection of sepsis-causing pathogens and antimicrobial resistance. Its products are designed to identify infections directly from whole-blood samples, potentially helping healthcare providers begin targeted treatment sooner than with conventional culture-based testing.

The company’s principal platform is the T2Dx Instrument, an automated diagnostic system that uses proprietary T2 Magnetic Resonance technology. Tests available for the platform have included T2Bacteria, which detects several common bacterial pathogens associated with bloodstream infections, and T2Candida, which detects Candida species linked to candidemia. T2 Biosystems has also developed tests intended to identify antimicrobial-resistance markers and pathogens associated with other serious infections.

Founded in 2006 and headquartered in Lexington, Massachusetts, T2 Biosystems markets its diagnostic products to hospitals, laboratories and other healthcare providers. The company serves customers in the United States and international markets through direct sales and distribution relationships. John Sperzel has served as the company’s president and chief executive officer.

Key Stats

• Today's Range: $0.0004 to $0.0095
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.05
• Volume: 9,454 shs
• Average Volume: 9,903 shs
• Market Capitalization: $178.22 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 11/13/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:TTOO
• Previous Symbol: NASDAQ:TTOO
• CIK: 1492674
• Web: www.t2biosystems.com
• Phone: (781) 761-4646
• Fax: 781-357-3080
• Employees: 113
• Year Founded: 2006

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $7.19 million
• Price / Sales: 0.02
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 18,760,000
• Free Float: N/A
• Market Cap: $168.84 thousand
• Optionable: No Data
• Beta: 8.42